Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Grant or award Director acquired 10,517 shares (grant or award)
  2. 4 Grant or award Director acquired 10,517 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 14,513 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 14,513 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale President & Chief Exec Officer sold 12,022 shares at $13.13 ($157,791)
  11. 4 Open-market sale Sr. VP & Chief Scientific Off. sold 13,000 shares at $13.29 ($172,795)
  12. 4 Open-market sale Sr. VP & Chief Comm. Officer sold 5,215 shares at $13.26 ($69,145)
  13. 4 Open-market sale SVP and CFO sold 15,285 shares at an average $13.28 ($202,969)
  14. 4 Shares withheld for taxes President & Chief Exec Officer gave up 43,038 shares (to pay taxes)
  15. 4 Shares withheld for taxes Sr VP & Chief Business Officer gave up 4,470 shares (to pay taxes)
  16. 4 Shares withheld for taxes Sr. VP & Chief Comm. Officer gave up 2,886 shares (to pay taxes)
  17. 4 Shares withheld for taxes President & Chief Exec Officer gave up 12,917 shares (to pay taxes)
  18. 4 Open-market sale SVP and CFO sold 1,825 shares at $12.20 ($22,265)
  19. 4 Shares withheld for taxes Sr VP & Chief Business Officer gave up 3,179 shares (to pay taxes)
  20. 4 Shares withheld for taxes Sr. VP & Chief Scientific Off. gave up 2,596 shares (to pay taxes)

Page 10 of 39 · 776 filings